Severe cutaneous adverse reactions and risk of autoimmune disease, including psoriasis and inflammatory bowel disease: a cohort study
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llaf344 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Tzu-Min Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical Universit…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Psoriasis, Inflammatory Bowel Diseases, Skin Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
Limited evidence exists about the association between autoimmune disease risk and patients with severe cutaneous adverse reactions (SCARs).
Objectives
To estimate the risks of a set of incident autoimmune outcomes in patients with SCARs.
Methods
We used the Taiwan National Health Insurance Research Database to build a cohort of 21 170 eligible individuals with SCARs and a matched non-SCARs cohort comprising 211 700 individuals. We analysed the autoimmune outcomes of interest through a Cox proportional hazards model.
Results
During a mean follow-up period of 5.2 years (SD 2.6 years), 459 of 21 170 (2.2%) individuals with and 299 of 211 700 (0.1%) without SCARs developed incident autoimmune disease, respectively. The incidence rate of any autoimmune disease was 418.5 events per 100 000 person-years among patients with SCARs and 27.0 events per 100 000 person-years among those without SCARs and the adjusted hazard ratio of any autoimmune disease was 15.5 (95% confidence interval 13.4–17.9). Furthermore, there was increased risk of an array of incident autoimmune disease, including systemic vasculitis, type 1 diabetes mellitus, Henoch–Schönlein purpura, primary Sjögren syndrome, Addison disease, systemic lupus erythematosus, systemic sclerosis, inflammatory bowel disease (ulcerative colitis and Crohn disease), myasthenia gravis, Hashimoto thyroiditis, psoriasis, rheumatoid arthritis, ankylosing spondylitis, Graves disease and autoimmune haemolytic anaemia.
Conclusions
This study suggests that patients with SCARs have a higher risk of developing autoimmune diseases than patients without SCARs. Further research investigating the underlying mechanisms is warranted. Physicians should be attentive to potential sequelae that may arise following SCARs resolution during long-term follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan.
- Division of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei City, Taiwan.
- Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
- Division of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan.
- Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taipei Veterans General Hospital, National Yang-Ming University, Taipei City, Taiwan.
- Health Data Analytics and Statistics Center, Office of Data Science, Taipei Medical University, Taipei City, Taiwan.
ORCID-Profile: Chi-Ching Chang
Zitieren
APA
Lin, T. M., Chang, Y. S., Shen, Y. C., Hsu, H. C., Chen, W. S., Lee, H. Y., Kuo, T. T., Chen, S. C., Chen, J. H., & Chang, C. C. (2025). Severe cutaneous adverse reactions and risk of autoimmune disease, including psoriasis and inflammatory bowel disease: a cohort study. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf344
Vancouver
Lin TM, Chang YS, Shen YC, Hsu HC, Chen WS, Lee HY, et al. Severe cutaneous adverse reactions and risk of autoimmune disease, including psoriasis and inflammatory bowel disease: a cohort study. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf344
BibTeX
@article{Lin2025,
author = {Lin, Tzu-Min and Chang, Yu-Sheng and Shen, Yu-Chuan and Hsu, Hui-Ching and Chen, Wei-Sheng and Lee, Hsiang-Yen and Kuo, Tzu-Tung and Chen, Shu-Chuan and Chen, Jin-Hua and Chang, Chi-Ching},
title = {Severe cutaneous adverse reactions and risk of autoimmune disease, including psoriasis and inflammatory bowel disease: a cohort study},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llaf344}
}
EUVIMED